MARCHF5 and early-onset autosomal dominant Alzheimer disease: It has been reported that MITOL alleviates the pathology of Alzheimer’s disease via blocking generation of the amyloid-β oligomer [22] and is expected to be a potential drug discovery target for the treatment of neurodegenerative diseases [23].